Global expertise in pharma M&A and licensing
We have a successful track record in transaction outcomes in both pharma M&A and licensing. Our expertise brings a unique strategic and commercial insight within healthcare. This makes us ideally placed to support your business from strategic development, through to valuation/deal terms and, utlimately, to getting the deal done.
We offer a comprehensive range of deal related healthcare advisory services and we are trusted to deliver quality results to our clients. Our clients range from blue-chip corporations to small start-up entities across the globe. Our coverage includes pharmaceuticals, biologics, drug delivery systems, diagnostics, medical devices, including telemedicine, medical software. We are are also active in the CRO and CMO M&A. See what our clients say here.
Our experience of 23 years is gained from working with clients' pharma M&A and licensing in 38 countries and conducting more than 700 assignments.